Nebula Research & Development LLC Cv Rx, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,004 shares of CVRX stock, worth $158,908. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,004
Previous 13,418
3.09%
Holding current value
$158,908
Previous $118 Million
39.38%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$50.1 Million17.73% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$24.8 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$11.3 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$11.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$10.7 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $251M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...